- Home
- BLNK vs ALEC Comparison
BLNK vs ALEC Comparison
Compare BLNK & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- ALEC
- Stock Information
- Founded
- BLNK 2009
- ALEC 2013
- Country
- BLNK United States
- ALEC United States
- Employees
- BLNK N/A
- ALEC N/A
- Industry
- BLNK Industrial Specialties
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLNK Consumer Discretionary
- ALEC Health Care
- Exchange
- BLNK Nasdaq
- ALEC Nasdaq
- Market Cap
- BLNK 129.3M
- ALEC 124.0M
- IPO Year
- BLNK N/A
- ALEC 2019
- Fundamental
- Price
- BLNK $1.36
- ALEC $2.95
- Analyst Decision
- BLNK Buy
- ALEC Buy
- Analyst Count
- BLNK 8
- ALEC 8
- Target Price
- BLNK $2.54
- ALEC $4.50
- AVG Volume (30 Days)
- BLNK 3.4M
- ALEC 1.2M
- Earning Date
- BLNK 11-06-2025
- ALEC 11-05-2025
- Dividend Yield
- BLNK N/A
- ALEC N/A
- EPS Growth
- BLNK N/A
- ALEC N/A
- EPS
- BLNK N/A
- ALEC N/A
- Revenue
- BLNK $104,788,000.00
- ALEC $81,130,000.00
- Revenue This Year
- BLNK N/A
- ALEC N/A
- Revenue Next Year
- BLNK $19.30
- ALEC $196.86
- P/E Ratio
- BLNK N/A
- ALEC N/A
- Revenue Growth
- BLNK N/A
- ALEC 46.77
- 52 Week Low
- BLNK $0.63
- ALEC $0.87
- 52 Week High
- BLNK $2.32
- ALEC $6.37
- Technical
- Relative Strength Index (RSI)
- BLNK 70.55
- ALEC 62.76
- Support Level
- BLNK $1.28
- ALEC $2.71
- Resistance Level
- BLNK $1.44
- ALEC $3.00
- Average True Range (ATR)
- BLNK 0.11
- ALEC 0.22
- MACD
- BLNK 0.03
- ALEC -0.01
- Stochastic Oscillator
- BLNK 81.40
- ALEC 74.29
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.